Published July 20, 2017 | Version v1
Patent Open

USE OF METHYLNALTREXONE TO ATTENUATE TUMOR PROGRESSION

  • 1. University of Chicago
  • 2. Salix Pharmaceuticals

Contributors

Description

Presented herein are methods for preventing or treating tumor growth, tumor metastasis and/or abnormal proliferation of tumor cells in a subject, wherein the methods involve administration of a pharmaceutical composition comprising methylnaltrexone. Also presented herein are methods for inhibiting or slowing the growth of a tumor in a subject, wherein the methods include selecting a subject who is a suitable candidate for treatment with methylnaltrexone, and administering a composition comprising methylnaltrexone to the subject.

Files

US20170202832.pdf

Files (3.1 MB)

Name Size Download all
md5:2a0bd0e94b10e1ab3fa23891fd076696
3.1 MB Preview Download

Additional details

Identifiers

Patent application number
US 201715477724 A
Patent number
US 2017/0202832 A1
Other
oai:uchicago.tind.io:9484

Dates

Patent filed
2017-04-03

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Anesthesia and Critical Care